Ann E. Weber (Merck & Company)
Design and Synthesis of Selective DPP-4 Inhibitors: Discovery of JANUVIA(TM) (Stagliptin), A New Treatment for Type 2 Diabetes
Dr. Weber is a 1982 B.S. alumnus from Notre Dame
Calendars
- All Events
- Biochemistry Seminar
- Biophysics Seminar
- (CBBI) Chemistry, Biochemistry, Biology Interface Program
- Departmental Colloquium
- Heidelberg at Notre Dame
- IMPACT Lecture Series
- Inorganic Seminar
- J.P. Freeman Lectureship
- Nieuwland Lecture
- Organic Seminar
- Physical/Analytical Seminar
- Reilly Lecture
- Special Seminar